Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial.
Files
Publication date
2009
Authors
van Marrewijk, C.J.
Mujakovic, S.
Fransen, G.A.
Numans, Mattijs
de Wit, Niek
Muris, JW
van Oijen, Martijn G.H.
Jansen, J.B.
Grobbee, D.E.
Knottnerus, J.A.
Editors
Advisors
Supervisors
DOI
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
Keywords
Citation
van Marrewijk, C J, Mujakovic, S, Fransen, G A, Numans, M E, de Wit, N J, Muris, JW, van Oijen, M G H, Jansen, J B, Grobbee, D E, Knottnerus, J A & Laheij, R J F 2009, 'Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial.', The Lancet, vol. 373, no. 9659, pp. 215-225. < http://www.ncbi.nlm.nih.gov/pubmed/19150702 >